Injective price prediction: Will downside continue? INJ falls near daily low

Traders Union
All News
Crypto News
Injective drops 8.12% to $3.32 today

Highlights

INJ trades at $3.32, significantly below the MA-20 ($4.35), MA-50 ($4.68), and MA-200 ($9.10), reflecting persistent selling across all timeframes.
Momentum indicators including MACD, ADX, and negative Bull/Bear Power confirm continued downside, while oversold RSI (29.30), Stochastic RSI (16.26), and CCI (-123.94) suggest short-term relief risks remain minor.
INJ is expected to consolidate between $2.98 and $3.65 over the next 5 trading days; a close below $2.98 signals potential for further bearish breakout due to lack of dynamic support.

Oversold signals highlight downside risk amid sustained volatility

Momentum remains firmly negative, with both the MACD and ADX pointing to continued downside pressure. Oversold signals are triggered by the RSI (29.30), Stochastic RSI (16.26), and CCI (-123.94), highlighting the risk of short-term relief but with sellers still in control, as reflected by the negative Bull/Bear Power reading. The Awesome Oscillator also supports this ongoing bearish trend. INJ opened without a major gap from the previous session and has dropped 8.12%, now trading near today’s low after a move from $3.56 to $3.30, reflecting high intraday volatility and sustained selling throughout the session. Momentum signals and price action are aligned, both indicating clear intraday weakness.

Sideways consolidation expected as bearish risk dominates

For the next 5 trading days, the price is expected to remain within a volatility band relative to current levels of $2.98 to $3.65, keeping near-term volatility contained. There is a very high probability (more than 80%) of continued decline, while the likelihood of a rebound remains low. The baseline scenario sees INJ consolidating sideways in a narrow range. A bullish development would require a close above the Ichimoku Kijun at $4.52, potentially opening space for further gains. Conversely, if selling persists and the price falls below $2.98, a fresh bearish breakout could target new lows, given the absence of immediate technical support.

Viktoras Karapetjanc, expert at Traders Union, views the current INJ trend as bearish but notes the market is deeply oversold. He sees limited immediate bullish catalysts, given muted news flow and heavy technical pressure. Karapetjanc expects that volatility will persist but foresees INJ consolidating between $2.98 and $3.65 in the short term. He remains constructive, looking for structural signs of accumulation. "A decisive move above $4.52 would spark my interest for bullish positioning, but until then, I see an opportunity for patient buyers as the market searches for a bottom."

Previously it was reported that Injective continues to trade in a subdued range below its key moving averages, with persistent bearish momentum underscored by weak technical indicators such as a deeply oversold RSI and negative oscillators. The asset shows little sign of a near-term rebound, with sellers maintaining control and no clear weekly support, leaving it vulnerable to further declines unless resistance levels are decisively reclaimed.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.